Skip to content

Merging News

About
Contact
Home
Home
Privacy Policy

Merging News

Chiesi Group to Acquire KalVista Pharmaceuticals, Expanding its Global Rare Disease Portfolio – Business Wire

Leave a Comment / Pharma and Biotech / By

Chiesi Group to buy KalVista Pharmaceuticals, Expanding its Global Rare Disease Portfolio Business Wire

Source: news.google.com

← Previous Post

Related Posts

Alkermes plc Announces Agreement to Acquire Avadel Pharmaceuticals plc – PR Newswire

Day One Biopharmaceuticals to Acquire Mersana Therapeutics – GlobeNewswire

Leave a Comment Cancel Reply

Your email address will not be published. Required fields are marked *

Type here..

Name*

Email*

Website

Save my name, email, and website in this browser for the next time I comment.

Δ

Search

Recent Posts

Generational Group Advises on the Acquisition of OK Tire Kitchener Location by OK Tire Guelph Ownership Team – Business Wire
Irenic Acquisition Corp. Announces Completion of $220,000,000 Initial Public Offering – Business Wire
ActiveProspect Rebrands Verisk Marketing Solutions as InfutorData Following Acquisition – PR Newswire
Arlington Capital Partners Acquires ENERCON and Completes Merger With Its Portfolio Company POND – Business Wire
Willis launches Merger Protect to help manage M&A regulatory compliance costs – GlobeNewswire

Recent Comments

No comments to show.

Archives

April 2026
March 2026
February 2026
January 2026
December 2025
November 2025
October 2025
September 2025
August 2025
July 2025
June 2025
May 2025
April 2025
March 2025

Categories

Bankruptcy
Energy and Materials
Financial Services
Mega Deals
Pharma and Biotech
Tech and Software

About
Contact
Home
Home
Privacy Policy

Sign up to receive email updates, fresh news and more!

There was an error trying to submit your form. Please try again.

This field is required.

There was an error trying to submit your form. Please try again.

Copyright © 2026 Merging News | Powered by Merging News